SlideShare une entreprise Scribd logo
1  sur  41
Télécharger pour lire hors ligne
Annual Meeting of Stockholders
             June 25, 2008




1
Forward-Looking and
             Cautionary Statement
    This is an oral presentation which is accompanied by slides. Investors are
    This is an oral presentation which is accompanied by slides. Investors are
    urged to review Rite Aid’s SEC filings.
    urged to review Rite Aid’s SEC filings.
    During today’s presentation forward-looking statements may be made.
    During today’s presentation forward-looking statements may be made.
    Such statements are subject to certain risks and uncertainties that could
    Such statements are subject to certain risks and uncertainties that could
    cause actual results to differ materially from those expressed or implied in
    cause actual results to differ materially from those expressed or implied in
    the forward-looking statements. Consequently, all forward-looking
    the forward-looking statements. Consequently, all forward-looking
    statements made during this presentation are qualified by those risks,
    statements made during this presentation are qualified by those risks,
    uncertainties and other factors.
    uncertainties and other factors.
    Please reference Rite Aid’s SEC filings, which are available on its web site,
    Please reference Rite Aid’s SEC filings, which are available on its web site,
    for a detail description of factors that could cause actual results to differ
    for a detail description of factors that could cause actual results to differ
    materially from those expressed or implied in such forward-looking
    materially from those expressed or implied in such forward-looking
    statements.
    statements.
    Also during today’s presentation, a non-GAAP financial measure is
    Also during today’s presentation, a non-GAAP financial measure is
    referenced. The definition and purpose for using this measure and
    referenced. The definition and purpose for using this measure and
    historical and prospective reconciliations to the GAAP measure
    historical and prospective reconciliations to the GAAP measure
    are in our Form 8-K we furnished to the SEC which is available
    are in our Form 8-K we furnished to the SEC which is available
    on Rite Aid’s web site.
    on Rite Aid’s web site.
2
Mary Sammons
    Chairman, President & CEO
3
Completed the
Brooks Eckerd Acquisition
Completed the
    Brooks Eckerd Acquisition




5
A Stronger National Drugstore
           Chain with 5,000 Stores




    Rite Aid is the Largest Drugstore Chain in the
    Eastern US and the 3rd Largest in the Country

6
Strong Position in 73% of
    Our Major Markets
New York        Raleigh       Norfolk
Los Angeles     Lexington     Rochester
Pittsburgh      Sacramento    Charleston WVA
Philadelphia    San Diego     Lansing
Detroit         Seattle       Toledo
Boston          Spokane       Burlington
Atlanta         Bakersfield   Riverside CA
Baltimore       Providence    Richmond
Washington DC   Portland OR   Santa Barbara
Buffalo         Portland ME   Harrisburg
Strong Position in 73% of
      Our Major Markets
Hartford          Binghamton    Erie
Louisville        Monterey      Wheeling
Albany NY         Redding       Youngstown
Albany GA         Parkersburg   Johnstown
Greensboro
                  Syracuse      Wilkes-Barre
Grand Rapids
                  Flint         Medford
Fresno
                  Bangor        Greenville-
Charlottesville
                  Utica         New Bern
Greenville-
                  Yakima
Spartanburg
Charlotte
Benefits of the Acquisition
    ► Enhanced    competitive position
    ► Strong East coast market share
    ► Expected to accelerate revenue and
      earnings growth
    ► Expected annual net cost savings of
      approximately $300 million on
      a full run-rate basis
    ► Potential to further realize additional
      cost savings and revenue synergies

9
Great Progress Integrating
     Acquired Stores
► Integrated six new distribution centers
► Rite Aid assortments, private brand in all
  1,800+ stores
► Replaced systems in 2/3 of the stores

► 20% of minor remodels completed

► Consolidated back office functions like
  payroll and accounting
► Delivered more cost savings synergies,
  than originally expected
Improved Performance
    of Core Stores
► Same  store sales increased by 1.3%
► Pharmacy same store sales growth at 1.7%
► Front end same store sales up 0.7%
► Customer satisfaction improved
New Store Development
 Continued
120 New Customer World Stores
Increased Management
 Depth of Senior Team




 Rob Easley         Brian Fiala
Chief Operating    Executive VP,
                  Store Operations
    Officer
Successfully Complete the
     Integration




14
Our Progress to Date
     ► Systems   conversions complete
     ► Field management alignment complete
     ► Nearly all stores in close proximity
       combined
     ► Minor remodels complete in almost 70%
       of acquired stores

     On Track to Complete
     the Integration by October!

15
What We’re Hearing
     “I like the appearance of the store. It is much
     more open, wider and inviting.”
     “They are clean, organized and have a larger
     selection.”
     “I don’t have to wait for my prescriptions.”
     “Now I can find the stuff I need quickly.”
     “It’s easier to find make-up and over the
     counter medicine. The make-up is better
     organized with more selection.”
16
Sales Trends Improving
     in Acquired Stores




17
Closing the Gap
in Critical Categories
Closing the Gap
     in Critical Categories




19
Closing the Gap
in Critical Categories
Private Brand Penetration
     Improving




21
Increase Productivity
in ALL Stores
Focused on the
     Customer Experience




23
Our Health and Wellness Vision




24
Leader in Diabetes Care




25
Health Condition
     Marketing Programs




26
Immunizations




27
More In-Store Clinics




28
Capitalize on Success
     of Living More




29
Increase Industry Leading
     Generic Dispense Rate




30
Focus on Compliance

             Prescriptions x100




Source: IMS Health
31
Free Rite Aid Rx Savings Card

           ► Pilotin Michigan stores
           ► Savings on 10,000
             prescription drugs
             ▪ 400 generics at $8.99 for 30
               days; $15.99 for 90 days
             ▪ 20% discount on most other
               generics, most brands
             ▪ 10% off Rite Aid private brand,
               including 1,500+ over the
               counter medications
32
Aggressive Acquisition/
     File Buy Program




33
“Fill Up & Fuel Up”




34
Rite Aid Brand Sales Growth




35
Upgraded Photo Departments




36
More GNC Departments




37
Effectively Control Expenses


     A “Frugal” Mentality




38
New Store Development
     Continues




      85 new and relos for fy’09
39
Being Caring Neighbors




40
Building our Future




41

Contenu connexe

Tendances (9)

Kraft heinz
Kraft heinzKraft heinz
Kraft heinz
 
Sprouts Farmers Market Investor Deck - August 2019
Sprouts Farmers Market Investor Deck - August 2019Sprouts Farmers Market Investor Deck - August 2019
Sprouts Farmers Market Investor Deck - August 2019
 
GNC Presentation on Growth from 2011
GNC Presentation on Growth from 2011GNC Presentation on Growth from 2011
GNC Presentation on Growth from 2011
 
sysco Annual Reports2004
sysco Annual Reports2004sysco Annual Reports2004
sysco Annual Reports2004
 
Neil Kimberley Bevnet Dec 2013 Presentation
Neil Kimberley Bevnet Dec 2013 PresentationNeil Kimberley Bevnet Dec 2013 Presentation
Neil Kimberley Bevnet Dec 2013 Presentation
 
YUM 08 Guidance
YUM 08 GuidanceYUM 08 Guidance
YUM 08 Guidance
 
H.J. Heinz M&A Board meeting On the Proposed Acquisition
H.J. Heinz M&A  Board meeting On the Proposed AcquisitionH.J. Heinz M&A  Board meeting On the Proposed Acquisition
H.J. Heinz M&A Board meeting On the Proposed Acquisition
 
Promar Digest February 2015
Promar Digest February 2015Promar Digest February 2015
Promar Digest February 2015
 
Promar digest Feb 2015
Promar digest Feb 2015Promar digest Feb 2015
Promar digest Feb 2015
 

Similaire à rite aid _share holders

New freedom powerpoint_investor_presentation v13 02.06.13
New freedom powerpoint_investor_presentation v13 02.06.13New freedom powerpoint_investor_presentation v13 02.06.13
New freedom powerpoint_investor_presentation v13 02.06.13
Celadrin
 
Pcyg investor presentation_may_2013
Pcyg investor presentation_may_2013Pcyg investor presentation_may_2013
Pcyg investor presentation_may_2013
amy_ostler
 
Winn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDayWinn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDay
finance32
 
Winn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDayWinn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDay
finance32
 
Personal care physicians series b preferred investment presentation
Personal care physicians series b preferred investment presentationPersonal care physicians series b preferred investment presentation
Personal care physicians series b preferred investment presentation
PersonalCare
 
Q1 2014 Family Dollar Stores Earnings Conference Call Presentation
Q1 2014 Family Dollar Stores Earnings Conference Call PresentationQ1 2014 Family Dollar Stores Earnings Conference Call Presentation
Q1 2014 Family Dollar Stores Earnings Conference Call Presentation
familydollar22
 
The business of pharmacy january 2013 long version
The business of pharmacy january 2013 long versionThe business of pharmacy january 2013 long version
The business of pharmacy january 2013 long version
Gerry Spitzner
 
2013 annual-report 130108806067963477
2013 annual-report 1301088060679634772013 annual-report 130108806067963477
2013 annual-report 130108806067963477
carnesta
 
Pcyg investor presentation mwic
Pcyg investor presentation   mwicPcyg investor presentation   mwic
Pcyg investor presentation mwic
amy_ostler
 
quest diagnostics q2 2005
quest diagnostics q2 2005quest diagnostics q2 2005
quest diagnostics q2 2005
finance34
 

Similaire à rite aid _share holders (20)

B98a4b05 995f-e208-d60b-6fd299a05649
B98a4b05 995f-e208-d60b-6fd299a05649B98a4b05 995f-e208-d60b-6fd299a05649
B98a4b05 995f-e208-d60b-6fd299a05649
 
Sprouts Strategy 2020 and Beyond
Sprouts Strategy 2020 and BeyondSprouts Strategy 2020 and Beyond
Sprouts Strategy 2020 and Beyond
 
New freedom powerpoint_investor_presentation v13 02.06.13
New freedom powerpoint_investor_presentation v13 02.06.13New freedom powerpoint_investor_presentation v13 02.06.13
New freedom powerpoint_investor_presentation v13 02.06.13
 
Pcyg investor presentation_may_2013
Pcyg investor presentation_may_2013Pcyg investor presentation_may_2013
Pcyg investor presentation_may_2013
 
Winn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDayWinn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDay
 
Winn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDayWinn-DixieStoresIncInvestorDay
Winn-DixieStoresIncInvestorDay
 
Personal care physicians series b preferred investment presentation
Personal care physicians series b preferred investment presentationPersonal care physicians series b preferred investment presentation
Personal care physicians series b preferred investment presentation
 
Q1 2014 Family Dollar Stores Earnings Conference Call Presentation
Q1 2014 Family Dollar Stores Earnings Conference Call PresentationQ1 2014 Family Dollar Stores Earnings Conference Call Presentation
Q1 2014 Family Dollar Stores Earnings Conference Call Presentation
 
The business of pharmacy january 2013 long version
The business of pharmacy january 2013 long versionThe business of pharmacy january 2013 long version
The business of pharmacy january 2013 long version
 
Valeant Investor Day 2015 Presentation
Valeant Investor Day 2015 PresentationValeant Investor Day 2015 Presentation
Valeant Investor Day 2015 Presentation
 
Sprouts Markets 8/2014 Investor Deck
Sprouts Markets 8/2014 Investor DeckSprouts Markets 8/2014 Investor Deck
Sprouts Markets 8/2014 Investor Deck
 
Phivida investor presentation_nov_19
Phivida investor presentation_nov_19Phivida investor presentation_nov_19
Phivida investor presentation_nov_19
 
2017 Oregon Wine Symposium| Assessing the Health of Your Business
2017 Oregon Wine Symposium| Assessing the Health of Your Business2017 Oregon Wine Symposium| Assessing the Health of Your Business
2017 Oregon Wine Symposium| Assessing the Health of Your Business
 
S Lroducts And Ipportunity( D)
S Lroducts And Ipportunity( D)S Lroducts And Ipportunity( D)
S Lroducts And Ipportunity( D)
 
2013 annual-report 130108806067963477
2013 annual-report 1301088060679634772013 annual-report 130108806067963477
2013 annual-report 130108806067963477
 
Pcyg investor presentation mwic
Pcyg investor presentation   mwicPcyg investor presentation   mwic
Pcyg investor presentation mwic
 
Ppt inst short 2806 eng
Ppt inst short 2806 engPpt inst short 2806 eng
Ppt inst short 2806 eng
 
quest diagnostics q2 2005
quest diagnostics q2 2005quest diagnostics q2 2005
quest diagnostics q2 2005
 
Apresentação Institucional - Hypermarcas
Apresentação Institucional - HypermarcasApresentação Institucional - Hypermarcas
Apresentação Institucional - Hypermarcas
 
Gravitas nutraceutical consolidation & rollup
Gravitas nutraceutical consolidation & rollupGravitas nutraceutical consolidation & rollup
Gravitas nutraceutical consolidation & rollup
 

Plus de finance15

20040930_google_10Q
20040930_google_10Q20040930_google_10Q
20040930_google_10Q
finance15
 
2004_google_annual_report
2004_google_annual_report2004_google_annual_report
2004_google_annual_report
finance15
 
20050331_google_10Q
20050331_google_10Q20050331_google_10Q
20050331_google_10Q
finance15
 
20050630_google_10Q
20050630_google_10Q20050630_google_10Q
20050630_google_10Q
finance15
 
20050930_google_10Q
20050930_google_10Q20050930_google_10Q
20050930_google_10Q
finance15
 
2005_google_annual_report
2005_google_annual_report2005_google_annual_report
2005_google_annual_report
finance15
 
20060331_google_10Q
20060331_google_10Q20060331_google_10Q
20060331_google_10Q
finance15
 
20060630_google_10Q
20060630_google_10Q20060630_google_10Q
20060630_google_10Q
finance15
 
20060930_google_10Q
20060930_google_10Q20060930_google_10Q
20060930_google_10Q
finance15
 
2006Q3_google_earnings_slides
2006Q3_google_earnings_slides2006Q3_google_earnings_slides
2006Q3_google_earnings_slides
finance15
 
2006Q4_google_earnings_slides
2006Q4_google_earnings_slides2006Q4_google_earnings_slides
2006Q4_google_earnings_slides
finance15
 
20070331_google_10Q
20070331_google_10Q20070331_google_10Q
20070331_google_10Q
finance15
 
2007Q1_google_earnings_slides
2007Q1_google_earnings_slides2007Q1_google_earnings_slides
2007Q1_google_earnings_slides
finance15
 
2007Q2_google_earnings_slides
2007Q2_google_earnings_slides2007Q2_google_earnings_slides
2007Q2_google_earnings_slides
finance15
 
20070930_google_10Q
20070930_google_10Q20070930_google_10Q
20070930_google_10Q
finance15
 
2007Q3_google_earnings_slides
2007Q3_google_earnings_slides2007Q3_google_earnings_slides
2007Q3_google_earnings_slides
finance15
 
2007_google_annual_report
2007_google_annual_report2007_google_annual_report
2007_google_annual_report
finance15
 
2007Q4_google_earnings_slides
2007Q4_google_earnings_slides2007Q4_google_earnings_slides
2007Q4_google_earnings_slides
finance15
 
2008Q1_google_earnings_slides
2008Q1_google_earnings_slides2008Q1_google_earnings_slides
2008Q1_google_earnings_slides
finance15
 
2008Q2_google_earnings_slides
2008Q2_google_earnings_slides2008Q2_google_earnings_slides
2008Q2_google_earnings_slides
finance15
 

Plus de finance15 (20)

20040930_google_10Q
20040930_google_10Q20040930_google_10Q
20040930_google_10Q
 
2004_google_annual_report
2004_google_annual_report2004_google_annual_report
2004_google_annual_report
 
20050331_google_10Q
20050331_google_10Q20050331_google_10Q
20050331_google_10Q
 
20050630_google_10Q
20050630_google_10Q20050630_google_10Q
20050630_google_10Q
 
20050930_google_10Q
20050930_google_10Q20050930_google_10Q
20050930_google_10Q
 
2005_google_annual_report
2005_google_annual_report2005_google_annual_report
2005_google_annual_report
 
20060331_google_10Q
20060331_google_10Q20060331_google_10Q
20060331_google_10Q
 
20060630_google_10Q
20060630_google_10Q20060630_google_10Q
20060630_google_10Q
 
20060930_google_10Q
20060930_google_10Q20060930_google_10Q
20060930_google_10Q
 
2006Q3_google_earnings_slides
2006Q3_google_earnings_slides2006Q3_google_earnings_slides
2006Q3_google_earnings_slides
 
2006Q4_google_earnings_slides
2006Q4_google_earnings_slides2006Q4_google_earnings_slides
2006Q4_google_earnings_slides
 
20070331_google_10Q
20070331_google_10Q20070331_google_10Q
20070331_google_10Q
 
2007Q1_google_earnings_slides
2007Q1_google_earnings_slides2007Q1_google_earnings_slides
2007Q1_google_earnings_slides
 
2007Q2_google_earnings_slides
2007Q2_google_earnings_slides2007Q2_google_earnings_slides
2007Q2_google_earnings_slides
 
20070930_google_10Q
20070930_google_10Q20070930_google_10Q
20070930_google_10Q
 
2007Q3_google_earnings_slides
2007Q3_google_earnings_slides2007Q3_google_earnings_slides
2007Q3_google_earnings_slides
 
2007_google_annual_report
2007_google_annual_report2007_google_annual_report
2007_google_annual_report
 
2007Q4_google_earnings_slides
2007Q4_google_earnings_slides2007Q4_google_earnings_slides
2007Q4_google_earnings_slides
 
2008Q1_google_earnings_slides
2008Q1_google_earnings_slides2008Q1_google_earnings_slides
2008Q1_google_earnings_slides
 
2008Q2_google_earnings_slides
2008Q2_google_earnings_slides2008Q2_google_earnings_slides
2008Q2_google_earnings_slides
 

rite aid _share holders

  • 1. Annual Meeting of Stockholders June 25, 2008 1
  • 2. Forward-Looking and Cautionary Statement This is an oral presentation which is accompanied by slides. Investors are This is an oral presentation which is accompanied by slides. Investors are urged to review Rite Aid’s SEC filings. urged to review Rite Aid’s SEC filings. During today’s presentation forward-looking statements may be made. During today’s presentation forward-looking statements may be made. Such statements are subject to certain risks and uncertainties that could Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in cause actual results to differ materially from those expressed or implied in the forward-looking statements. Consequently, all forward-looking the forward-looking statements. Consequently, all forward-looking statements made during this presentation are qualified by those risks, statements made during this presentation are qualified by those risks, uncertainties and other factors. uncertainties and other factors. Please reference Rite Aid’s SEC filings, which are available on its web site, Please reference Rite Aid’s SEC filings, which are available on its web site, for a detail description of factors that could cause actual results to differ for a detail description of factors that could cause actual results to differ materially from those expressed or implied in such forward-looking materially from those expressed or implied in such forward-looking statements. statements. Also during today’s presentation, a non-GAAP financial measure is Also during today’s presentation, a non-GAAP financial measure is referenced. The definition and purpose for using this measure and referenced. The definition and purpose for using this measure and historical and prospective reconciliations to the GAAP measure historical and prospective reconciliations to the GAAP measure are in our Form 8-K we furnished to the SEC which is available are in our Form 8-K we furnished to the SEC which is available on Rite Aid’s web site. on Rite Aid’s web site. 2
  • 3. Mary Sammons Chairman, President & CEO 3
  • 5. Completed the Brooks Eckerd Acquisition 5
  • 6. A Stronger National Drugstore Chain with 5,000 Stores Rite Aid is the Largest Drugstore Chain in the Eastern US and the 3rd Largest in the Country 6
  • 7. Strong Position in 73% of Our Major Markets New York Raleigh Norfolk Los Angeles Lexington Rochester Pittsburgh Sacramento Charleston WVA Philadelphia San Diego Lansing Detroit Seattle Toledo Boston Spokane Burlington Atlanta Bakersfield Riverside CA Baltimore Providence Richmond Washington DC Portland OR Santa Barbara Buffalo Portland ME Harrisburg
  • 8. Strong Position in 73% of Our Major Markets Hartford Binghamton Erie Louisville Monterey Wheeling Albany NY Redding Youngstown Albany GA Parkersburg Johnstown Greensboro Syracuse Wilkes-Barre Grand Rapids Flint Medford Fresno Bangor Greenville- Charlottesville Utica New Bern Greenville- Yakima Spartanburg Charlotte
  • 9. Benefits of the Acquisition ► Enhanced competitive position ► Strong East coast market share ► Expected to accelerate revenue and earnings growth ► Expected annual net cost savings of approximately $300 million on a full run-rate basis ► Potential to further realize additional cost savings and revenue synergies 9
  • 10. Great Progress Integrating Acquired Stores ► Integrated six new distribution centers ► Rite Aid assortments, private brand in all 1,800+ stores ► Replaced systems in 2/3 of the stores ► 20% of minor remodels completed ► Consolidated back office functions like payroll and accounting ► Delivered more cost savings synergies, than originally expected
  • 11. Improved Performance of Core Stores ► Same store sales increased by 1.3% ► Pharmacy same store sales growth at 1.7% ► Front end same store sales up 0.7% ► Customer satisfaction improved
  • 12. New Store Development Continued 120 New Customer World Stores
  • 13. Increased Management Depth of Senior Team Rob Easley Brian Fiala Chief Operating Executive VP, Store Operations Officer
  • 14. Successfully Complete the Integration 14
  • 15. Our Progress to Date ► Systems conversions complete ► Field management alignment complete ► Nearly all stores in close proximity combined ► Minor remodels complete in almost 70% of acquired stores On Track to Complete the Integration by October! 15
  • 16. What We’re Hearing “I like the appearance of the store. It is much more open, wider and inviting.” “They are clean, organized and have a larger selection.” “I don’t have to wait for my prescriptions.” “Now I can find the stuff I need quickly.” “It’s easier to find make-up and over the counter medicine. The make-up is better organized with more selection.” 16
  • 17. Sales Trends Improving in Acquired Stores 17
  • 18. Closing the Gap in Critical Categories
  • 19. Closing the Gap in Critical Categories 19
  • 20. Closing the Gap in Critical Categories
  • 23. Focused on the Customer Experience 23
  • 24. Our Health and Wellness Vision 24
  • 26. Health Condition Marketing Programs 26
  • 29. Capitalize on Success of Living More 29
  • 30. Increase Industry Leading Generic Dispense Rate 30
  • 31. Focus on Compliance Prescriptions x100 Source: IMS Health 31
  • 32. Free Rite Aid Rx Savings Card ► Pilotin Michigan stores ► Savings on 10,000 prescription drugs ▪ 400 generics at $8.99 for 30 days; $15.99 for 90 days ▪ 20% discount on most other generics, most brands ▪ 10% off Rite Aid private brand, including 1,500+ over the counter medications 32
  • 33. Aggressive Acquisition/ File Buy Program 33
  • 34. “Fill Up & Fuel Up” 34
  • 35. Rite Aid Brand Sales Growth 35
  • 38. Effectively Control Expenses A “Frugal” Mentality 38
  • 39. New Store Development Continues 85 new and relos for fy’09 39